Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience.
Wakabayashi H, Kayano D, Inaki A, Araki R, Kuroda R, Ikawa Y, Fujiki T, Akatani N, Yamase T, Watanabe S, Hiromasa T, Kunita Y, Mori H, Saito S, Nishimura R, Wada T, Kinuya S. Wakabayashi H, et al. Among authors: wada t. Ann Nucl Med. 2020 Nov;34(11):840-846. doi: 10.1007/s12149-020-01514-2. Epub 2020 Aug 29. Ann Nucl Med. 2020. PMID: 32862362
High-dose Methotrexate-induced Acral Erythema in Two Pediatric Patients With Acute Lymphoblastic Leukemia: A 17 Pediatric Case Series of Methotrexate-induced Acral Erythema.
Noguchi K, Nishimura R, Ikawa Y, Mase S, Fujiki T, Kuroda R, Araki R, Maeba H, Yachie A, Wada T. Noguchi K, et al. Among authors: wada t. J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1259-e1261. doi: 10.1097/MPH.0000000000002326. J Pediatr Hematol Oncol. 2021. PMID: 34486565 Review. No abstract available.
Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation.
Kuroda R, Wakabayashi H, Araki R, Inaki A, Nishimura R, Ikawa Y, Yoshimura K, Murayama T, Imai Y, Funasaka T, Wada T, Kinuya S. Kuroda R, et al. Among authors: wada t. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1574-1583. doi: 10.1007/s00259-021-05630-7. Epub 2021 Nov 27. Eur J Nucl Med Mol Imaging. 2022. PMID: 34837510 Clinical Trial.
4,472 results